Dragana Jovanović

734 total citations
43 papers, 167 citations indexed

About

Dragana Jovanović is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Dragana Jovanović has authored 43 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 11 papers in Physiology. Recurrent topics in Dragana Jovanović's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Sarcoidosis and Beryllium Toxicity Research (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Dragana Jovanović is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Sarcoidosis and Beryllium Toxicity Research (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Dragana Jovanović collaborates with scholars based in Serbia, Türkiye and Czechia. Dragana Jovanović's co-authors include Vesna Škodrić-Trifunović, Milica Kontić, Jelena Marković, Martina Vašáková, Martina Šterclová, Jasna Tekavec-Trkanjec, Nesrin Moğulkoç, Veronika Müller, Violeta Mihailović-Vučinić and Mihailo Stjepanović and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and CHEST Journal.

In The Last Decade

Dragana Jovanović

38 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dragana Jovanović Serbia 7 103 60 41 22 21 43 167
Yuya Shirai Japan 5 54 0.5× 89 1.5× 101 2.5× 17 0.8× 13 0.6× 14 196
Anna D’Agostino Italy 9 131 1.3× 22 0.4× 27 0.7× 26 1.2× 15 0.7× 17 244
Alessia Comes Italy 7 157 1.5× 85 1.4× 35 0.9× 22 1.0× 5 0.2× 12 220
Łukasz Kasper Poland 9 114 1.1× 18 0.3× 137 3.3× 34 1.5× 19 0.9× 17 248
S. Jaffré France 8 74 0.7× 11 0.2× 32 0.8× 23 1.0× 13 0.6× 13 151
Damien Vansteene France 8 69 0.7× 106 1.8× 53 1.3× 29 1.3× 43 2.0× 25 202
Iria González Spain 6 26 0.3× 62 1.0× 16 0.4× 24 1.1× 27 1.3× 18 175
Marco Rabusin Italy 6 29 0.3× 17 0.3× 38 0.9× 34 1.5× 33 1.6× 31 148
Elisa Seneca Italy 4 50 0.5× 20 0.3× 35 0.9× 40 1.8× 14 0.7× 8 204
Eulogio Rodríguez-Becerra Spain 8 241 2.3× 11 0.2× 79 1.9× 43 2.0× 16 0.8× 10 285

Countries citing papers authored by Dragana Jovanović

Since Specialization
Citations

This map shows the geographic impact of Dragana Jovanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dragana Jovanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dragana Jovanović more than expected).

Fields of papers citing papers by Dragana Jovanović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dragana Jovanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dragana Jovanović. The network helps show where Dragana Jovanović may publish in the future.

Co-authorship network of co-authors of Dragana Jovanović

This figure shows the co-authorship network connecting the top 25 collaborators of Dragana Jovanović. A scholar is included among the top collaborators of Dragana Jovanović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dragana Jovanović. Dragana Jovanović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kostic, Jelena, et al.. (2023). Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis. Radiology and Oncology. 57(1). 12–19. 2 indexed citations
3.
4.
Májek, Ondřej, Jakub Gregor, Nesrin Moğulkoç, et al.. (2022). Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone. PLoS ONE. 17(9). e0273854–e0273854. 6 indexed citations
5.
Šterclová, Martina, Nesrin Moğulkoç, Katarzyna Lewandowska, et al.. (2021). Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries. Frontiers in Medicine. 8. 729203–729203. 8 indexed citations
6.
Jovanović, Dragana. (2021). Etiopathogenesis of malignant pleural effusion. AME Medical Journal. 6. 28–28. 6 indexed citations
7.
Šterclová, Martina, Nesrin Moğulkoç, Jan Kuś, et al.. (2020). Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE. Drug Safety. 43(10). 971–980. 11 indexed citations
8.
Jovanović, Dragana, et al.. (2020). Correlation of genomic alterations and PD-L1 expression in thymoma. Journal of Thoracic Disease. 12(12). 7561–7570. 6 indexed citations
9.
Jovanović, Dragana, et al.. (2019). Tuberculosis outbreak among high school students in Novi Pazar, Serbia 2016: a retrospective-cohort study. The Journal of Infection in Developing Countries. 13(2). 101–110. 8 indexed citations
10.
Jovanović, Dragana, et al.. (2018). Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis—a pilot study. Journal of Thoracic Disease. 10(12). 6660–6669. 41 indexed citations
11.
Jovanović, Dragana, et al.. (2017). Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report. OncoTargets and Therapy. Volume 10. 4347–4354. 3 indexed citations
12.
Kontić, Milica, et al.. (2016). A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer. Journal of Thoracic Disease. 8(6). 1029–1031. 11 indexed citations
13.
Šumarac, Zorica, et al.. (2014). Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls. European Respiratory Journal. 44(Suppl 58). 1735–1735. 1 indexed citations
14.
Jovanović, Dragana, et al.. (2014). Clinical features of endobronchial tuberculosis. Vojnosanitetski pregled. 71(2). 156–160. 7 indexed citations
15.
Pešut, Dragica, et al.. (2014). Amiodarone pulmonary toxicity: Case report. Srpski arhiv za celokupno lekarstvo. 142(7-8). 480–483. 1 indexed citations
16.
Jovanović, Dragana, et al.. (2013). Changes in electrocardiogram in patients with cardiac sarcoidosis. Medicinski pregled. 66(suppl. 1). 47–49. 1 indexed citations
17.
Mašulović, Dragan, et al.. (2010). Ultrasonographyin diagnosis of thoracic diseases. Medicinski pregled. 63(1-2). 86–90. 2 indexed citations
18.
Milenković, Branislava, et al.. (2009). TRACHEOBRONCHIAL TUMORS: A REVIEW OF 50 CASES. CHEST Journal. 136(4). 21S–21S. 1 indexed citations
19.
Petrović, Marina, et al.. (2009). Risk factors for brain metastases after definitive chemoradiation for locally advanced non-small cell lung cancer. Vojnosanitetski pregled. 66(11). 876–880. 1 indexed citations
20.
Jovanović, Dragana, et al.. (2008). Economic aspects of hospital treated pneumococcal pneumonia and the results of Pneumo 23 vaccine use in Serbia. Srpski arhiv za celokupno lekarstvo. 136(11-12). 625–628. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuya Shirai Breakdown of academic impact, for papers by Anna D’Agostino Breakdown of academic impact, for papers by Alessia Comes Breakdown of academic impact, for papers by Łukasz Kasper Breakdown of academic impact, for papers by S. Jaffré Breakdown of academic impact, for papers by Damien Vansteene Breakdown of academic impact, for papers by Iria González Breakdown of academic impact, for papers by Marco Rabusin Breakdown of academic impact, for papers by Elisa Seneca Breakdown of academic impact, for papers by Eulogio Rodríguez-Becerra
Rankless by CCL
2026